Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: DIGOXIN

« Back to Dashboard
Digoxin is a drug marketed by Roxane, Abraxis Pharm, Eurohlth Intl Sarl, Hospira, Sandoz, Wyeth Ayerst, Hikma Intl Pharms, Impax Labs, Mylan Pharms Inc, Stevens J, and Sun Pharm Inds Inc. and is included in thirteen NDAs. It is available from three suppliers.

The generic ingredient in DIGOXIN is digoxin. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the digoxin profile page.

Summary for Tradename: DIGOXIN

Patents:0
Applicants:11
NDAs:13
Suppliers / Packagers: see list4

Pharmacology for Tradename: DIGOXIN

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside

Clinical Trials for: DIGOXIN

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care
Status: Completed Condition: Heart Failure

Drug Interaction Study of Isavuconazole and Digoxin
Status: Completed Condition: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Digoxin; Healthy Volunteers

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects
Status: Completed Condition: Healthy Subjects; Pharmacokinetics; Drug-Drug Interaction (DDI)

Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients
Status: Recruiting Condition: Atrial Fibrillation

A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults
Status: Completed Condition: Healthy Volunteer

to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers
Status: Completed Condition: Healthy

A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin
Status: Completed Condition: Healthy

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin
Status: Completed Condition: Healthy; HIV Infections

An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed
Status: Completed Condition: Epilepsy

Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects
Status: Completed Condition: Alzheimer Disease; Huntington Disease

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.
Status: Completed Condition: Healthy

A Drug Interaction Study of Albiglutide and Digoxin
Status: Completed Condition: Diabetes Mellitus, Type 2; Healthy

Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin
Status: Completed Condition: DRUG REACTIONS

Efficacy Study of Digoxin & Ivabradine to Treat Heart Failure
Status: Completed Condition: Cardiac Failure

A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects
Status: Completed Condition: Healthy; Pharmacokinetic of Digoxin

Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients
Status: Completed Condition: Type 2 Diabetes Mellitus

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer
Status: Completed Condition: Metastatic ErbB2; Neoplasms, Breast; Breast Cancer

Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib
Status: Completed Condition: Healthy Volunteers

Drug Interaction Study of Digoxin and BI 10773
Status: Completed Condition: Healthy

Intra Amniotic Injection of DIGOXIN for Feticide in Second Trimester Termination of Pregnancy
Status: Not yet recruiting Condition: Arrhythmia; ECG Changes; Hypotension

A Trial of Digoxin Before Second-Trimester Abortion
Status: Completed Condition: Induced Abortion

Digoxin Withdrawal in Stable Heart Failure
Status: Completed Condition: Heart Failure

Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
Status: Completed Condition: Abortion, Induced

A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178
Status: Completed Condition: Healthy

Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects
Status: Completed Condition: Healthy Volunteers; Rheumatoid Arthritis

Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin
Status: Completed Condition: Healthy

Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction
Status: Recruiting Condition: Heart Failure

A Study of Evacetrapib and Digoxin in Healthy Participants
Status: Completed Condition: Healthy Volunteers

Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function
Status: Completed Condition: Cardiac Failure With Sinus Rhythm or Atrial Fibrillation.

Capecitabine With Digoxin for Metastatic Breast Cancer
Status: Recruiting Condition: Metastatic Breast Cancer

The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects
Status: Recruiting Condition: Healthy

A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants
Status: Completed Condition: Healthy Volunteers

A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma
Status: Completed Condition: Malignant Melanoma, Neoplasms

Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects
Status: Completed Condition: N/A - Healthy Subjects

Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy Volunteers
Status: Completed Condition: Healthy

A Prospective Study of Different Digoxin Treatment Regimens in Egyptian Hospital
Status: Completed Condition: Atrial Fibrillation

Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma
Status: Recruiting Condition: Kaposi' s Sarcoma; Classic Kaposi' s Sarcoma; Endemic Kaposi' s Sarcoma; Lymph Angio Proliferations

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
Status: Terminated Condition: Carcinoma, Non-Small Cell Lung

TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin
Status: Completed Condition: Hepatitis C Virus

Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin
Status: Completed Condition: Healthy Volunteers; Pharmacokinetics

A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
Status: Completed Condition: Diabetes Mellitus, Type 2

DIG-HIF1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer
Status: Recruiting Condition: Breast Cancer

A Study of LY2216684 and Digoxin in Healthy Subjects
Status: Completed Condition: Major Depressive Disorder

A Drug-Drug Interaction Study of Digoxin and PA21
Status: Completed Condition: Drug Interaction Potentiation

Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
Status: Completed Condition: Type 2 Diabetes Mellitus

Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult Subjects
Status: Recruiting Condition: Healthy

Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.
Status: Active, not recruiting Condition: Neoplasms

Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin
Status: Withdrawn Condition: Healthy

The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin
Status: Completed Condition: Epilepsy

A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of TAK-272 and the Effect of TAK-272 on the Pharmacokinetics of Digoxin and Midazolam
Status: Completed Condition: Japanese Healthy Adult Males

Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
Status: Completed Condition: Diabetes; Healthy

Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects
Status: Completed Condition: Diabetes; Healthy

DDI Study With Multiple-dose LX4211 and Single Dose Digoxin
Status: Completed Condition: Healthy

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects
Status: Completed Condition: Solid Tumors

A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma
Status: Recruiting Condition: Melanoma

Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of Digoxin
Status: Completed Condition: Healthy

A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers
Status: Completed Condition: Healthy Volunteer

Digoxin for Recurrent Prostate Cancer
Status: Completed Condition: Prostate Cancer

Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
Status: Not yet recruiting Condition: Permanent Atrial Fibrillation

A Preliminary Drug Drug Interaction Study With TA-8995
Status: Completed Condition: Pharmacokinetic Interactions

An Interaction Study With Digoxin and AZD1305
Status: Completed Condition: Atrial Fibrillation

Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers
Status: Completed Condition: Healthy

A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil
Status: Completed Condition: Healthy Subjects

A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
Status: Completed Condition: Drug-drug Interaction Study

A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers
Status: Completed Condition: Essential Hypertension

An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects
Status: Completed Condition: Chemotherapy-induced Nausea and Vomiting

Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure
Status: Withdrawn Condition: Heart Failure

Antibodies to Digoxin for Bipolar Disorder
Status: Completed Condition: Bipolar Disorder

Efficacy Study of Digibind for Treatment of Severe Preeclampsia
Status: Completed Condition: Pre-eclampsia

Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn
Status: Completed Condition: Heart Diseases

The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)
Status: Completed Condition: Healthy

Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes
Status: Recruiting Condition: Depression

Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients
Status: Not yet recruiting Condition: Rheumatoid Arthritis

An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers
Status: Completed Condition: Healthy Volunteers

Drug-Drug Interaction Study in Health Adult Volunteers
Status: Completed Condition: Healthy

Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin
Status: Completed Condition: Alzheimer Disease

Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
Status: Completed Condition: Diabetes; Healthy

Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers
Status: Completed Condition: Healthy

Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia
Status: Completed Condition: Supraventricular Tachycardia

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers
Status: Completed Condition: Healthy

Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease
Status: Active, not recruiting Condition: Hypertension; Hemodialysis

Digoxin Drug-Drug Interaction With Lurasidone HCl
Status: Completed Condition: Schizophrenia

Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein
Status: Active, not recruiting Condition: AOD Effects and Consequences

A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
Status: Active, not recruiting Condition: Cutaneous Warts

Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services
Status: Recruiting Condition: Legally Induced Abortion Without Mention of Complication

Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects
Status: Completed Condition: Hepatitis C

Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department
Status: Recruiting Condition: Atrial Fibrillation

Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)
Status: Completed Condition: Atrial Fibrillation

Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation
Status: Active, not recruiting Condition: Postoperative Atrial Fibrillation

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone
Status: Recruiting Condition: Substance-Related Disorders

Retrospective Evaluation of Carvedilol Versus Captopril in CHF Patients
Status: Terminated Condition: Heart Failure; Heart Murmurs

Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
Status: Completed Condition: Abortion, Induced

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
Status: Completed Condition: Atrial Fibrillation; Arrhythmia

Effect of Garlic Supplements on Opioids in Healthy Volunteers
Status: Completed Condition: Healthy, no Evidence of Disease

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
Status: Completed Condition: Arrhythmia; Atrial Fibrillation; Cardiovascular Diseases; Heart Diseases

Pulmonary Arterial Denervation in Patients With Pulmonary Arterial Hypertension Associated With the Left Heart Failure
Status: Recruiting Condition: Pulmonary Hypertension

Effects of Amlodipine in the Management of Chronic Heart Failure
Status: Suspended Condition: Chronic Heart Failure

Rhythm Control of AF in Patients With Acute Stroke
Status: Not yet recruiting Condition: Atrial Fibrillation

Remission From Stage D Heart Failure
Status: Recruiting Condition: NYHA Class IIIB/IV Patients Eligible for HeartMate II Implant Either as BTT or DT

Catheter Ablation Versus Medical Treatment of AF in Heart Failure
Status: Recruiting Condition: Atrial Fibrillation; Heart Failure

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
DIGOXIN
digoxin
ELIXIR;ORAL021648-001Aug 26, 2004RXYes<disabled><disabled>
Hospira
DIGOXIN PEDIATRIC
digoxin
INJECTABLE;INJECTION040092-001Apr 25, 1996DISCNNo<disabled><disabled>
Wyeth Ayerst
DIGOXIN
digoxin
INJECTABLE;INJECTION084386-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Hospira
DIGOXIN
digoxin
INJECTABLE;INJECTION040093-001May 16, 1996DISCNNo<disabled><disabled>
Mylan Pharms Inc
DIGOXIN
digoxin
TABLET;ORAL040282-001Dec 23, 1999RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc